We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Marker for Iron Availability Derived From Blood Test

By LabMedica International staff writers
Posted on 18 Jul 2011
Low hemoglobin density (LHD%) is a new parameter provided by an autoanalyzer that can be derived from the mean cell hemoglobin concentration. More...


The diagnosis of iron deficiency or functional iron deficiency is particularly challenging in patients with acute or chronic inflammatory conditions because most of the biochemical markers for iron metabolism are affected by acute phase reaction.

Scientists at the Hospital Galdakao – Usansolo, (Galdakao, Spain), used the program of the LH 780 analyzer to study 110 patients with iron deficiency (IDA); 65 with chronic kidney disease (CKD), and 85 with anemia of chronic disease (ACD), 24 of whom were iron deficient and 61 were iron sufficient and 90 healthy subjects. A total of 350 peripheral blood samples were analyzed during the 2-month period from March 2010 to April 2010.

Low hemoglobin density values showed no statistical difference in patients with IDA and patients with ACD accompanied with IDA. The LHD% values in these patients were significantly different compared with the iron-sufficient patients with ACD. Receiver operating characteristic (ROC) curve analysis for LHD% in the detection of iron deficiency showed the following: area under curve 0.903; cut off 5.5%, with a sensitivity of 88.6%, and a specificity of 76.9%.

The author concluded that in the present study the parameter, LHD% is useful for diagnosing iron deficiency and is a reliable parameter for recognizing subsets of anemic patients and therefore improving the diagnosis and management of anemia. The LHD% analysis can be performed simultaneously in the course of routine blood counts, with no incremental costs and no additional blood sampling. In conjunction with standard blood cell counts and iron parameters, LHD% could enable the diagnosis to be made rapid and accurately, when using the LH 780 analyzer (Beckman Coulter Inc., Miami, FL, USA). The study was published on July 4, 2011, in the International Journal of Laboratory Hematology.

Related Links:

Hospital Galdakao – Usansolo
Beckman Coulter Inc.



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Pancreas cells (left) showing early stages of malignant cancer in brown and same cells stained blue (right) indicate they are Integrin β3 (ITGB3) positive (Photo courtesy of UC San Diego Health Sciences)

Gene Signature Could Serve as Early Warning System for Aggressive Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal forms of cancer, with early detection remaining a major challenge. Precancerous cells must overcome significant stress and... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.